Limited overlapping roles of p15(INK4b) and p18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis

EMBO Journal

Volumn 19, Issue 13, 2000, Pages 3496-3506

  Latres, Esther ^a,e   Malumbres, Marcos ^a,b   Sotillo, Rocío ^a,b   Martín, Javier ^a,b   Ortega, Sagrario ^a,b   Martín Caballero, Juan ^b   Flores, Juana María ^c   Cordón Cardo, Carlos ^d   Barbacid, Mariano ^a,b  

^a Ctro Nac Invest Oncologicas C   (Spain)

^b CSIC   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell cycle inhibitors; Cyclin D dependent Cdk; Cysts; Lymphoproliferative disorders; Tumors

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P15; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; FIBROBLAST CULTURE; GENE TARGETING; HEMATOPOIESIS; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; ONCOGENE H RAS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALIA;

EID: 0034600841     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.13.3496     Document Type: Article

References (35)

1. Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem., 272, 25863-25872.
2. Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J., 18, 1571-1583.
3. 1 checkpoint control. Cell, 82, 675-684.
4. INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell. 7, 1587-1599.
5. Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev., 12, 2899-2911.
6. INK4 gene) during tumor progression in a sporadic melanoma patient. Cancer Res., 55, 5531-5535.
7. Glick, A.B., Sporn, M.B. and Yuspa, S.H. (1991) Altered regulation of TGF-β1 and TGF-β in primary keratinocytes and papillomas expressing v-Ha-ras. Mol. Carcinog., 4, 210-219.
8. Graham, F.L., and Van der Eb, A.J. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52, 456-467.
9. INK4b is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261.
10. INK4C in adult T-cell leukaemia and non-Hodgkin's lymphoma. Br. J. Haematol., 99, 665-667.
11. INK4b. Cancer Res., 56, 722-727.
12. Iavarone, A. and Massagué, J. (1997) Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature, 387, 417-422.
13. Joyner, A.L. (1993) In Rickwood, D. and Hames, B.D. (eds), Gene Targeting: A Practical Approach. Oxford University Press, Oxford, UK.
14. LaBaer, J., Garret, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. and Harlow, E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11, 847-862.
15. Lois, A.F., Cooper, L.T., Geng, Y., Nobori, T. and Carson, D. (1995) Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res., 55, 4010-4013.
16. INK4a alterations in murine primary T-cell lymphomas. Oncogene, 14, 1361-1370.
17. Miller, C.W., Aslo, A., Campbell, M.J., Kawamata, N., Lampkin, B.C. and Koeffler, H.P. (1996) Alterations of the p15, p16, and p18 genes in osteosarcoma. Cancer Genet. Cytogenet., 86, 136-142.
18. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
19. Morse, L. Chen, D., Franklin, D., Xiong, Y. and Chen-Kiang, S. (1997) Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. Immunity, 6, 47-56.
20. Nagahara, H., Ezhevsky, S.A., Vocero-Akbani, A.M., Kaldis, P., Solomon, M.J. and Dowdy, S.F. (1999) Transforming growth factor β targeted inactivation of cyclin e:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of cdk2 activating kinase activity. Proc. Natl Acad. Sci. USA. 96, 14961-14966.
21. Otsuki, T., Jaffe, E.S., Wellmann, A., Kumar, S., Condron, K.S. and Raffeld, M. (1996) Absence of p18 mutations or deletions in lymphoid malignancies. Leukemia, 10, 356-360.
22. Kip1. Cell Growth Differ., 9, 595-610.
23. INK4c expression during myogenesis. Mol. Cell. Biol., 18, 2334-2343.
24. Reynisdóttir, I., Polyak, K., Iavarone A. and Massagué, J. (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arest in response to TGF-β. Genes Dev., 9, 1831-1845.
25. Rusin, M.R. et al. (1996) Intragenic mutations of the p16(INK4a), p15(INK4b) and p18 genes in primary non-small-cell lung cancers. Int. J. Cancer, 65, 734-739.
26. Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D. and DePinho, R.A. (1996) Role of the INK4a locus in tumor suppression. Cell, 85, 27-37.
27. 1-phase progression. Genes Dev., 13, 1501-1512.
28. Soos, T.J. et al. (1996) Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ., 7, 135-146.
29. Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J.M., Tavtigian, S.V., Cannon-Albright, L. and Kamb, A. (1995) Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene, 11, 987-991.
30. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. and Mulligan, R.C. (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell, 65, 1153-1163.
31. Wuarin, J. and Nurse, P. (1996) Regulating S phase: CDKs, licensing and proteolysis. Cell, 85, 785-787.
32. ARF, is a candidate for the plasmacytoma susceptibility locus. Pctrl. Proc. Natl Acad. Sci. USA, 95, 2429-2434.
33. INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene, 15, 203-211.
34. Zindy, F., Soares, H., Herzog, K.H., Morgan, J., Sherr, C.J. and Roussel, M.F. (1997b) Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ., 8, 1139-1150.
35. Zindy, F., van Deursen, J., Grosveld, G., Sherr, C.J. and Roussel, M.F. (2000) INK4d-deficient mice are fertile despite testicular atrophy. Mol. Cell. Biol., 20, 372-378.